Surviving Heart Attack can be Prolonged With High-potency Statins

Chance of surviving a heart attack can be significantly improved by treatment with high-potency statins compared to those taking normal statins, suggests a study.

Patients who switched to a high-potency statin had a 28 percent lower risk of death compared to those who received normal statins.

Heart Attack - Overview
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.

The study, led by the University of Dundee, also found a combination of statins and the drug ezetimibe showed no improved survival rate.

"There is presently a lot of interest in ezetimibe as a potential treatment for heart patients," said Professor Chim Lang from University of Dundee in Scotland.

"The key question really is whether it is better than statins, especially high-potency statins such as rosuvastatin or atorvastatin," said Lang.

Tips to Prevent Heart Attacks
Heart Attack occurs when the flow of oxygenated blood to heart muscles is hindered or stopped due to built-up of plaques in coronary arteries. Heart Attack is the No.1 killer among Indians.

The study, looking at the data from thousands of patients in Britain, showed that patients who switched from normal statin treatment to high potency statins lived longer.

There was no observed benefit of adding ezetimibe.

Quiz on Heart Attack
The risk factors that work behind the scene before a heart attack are familiar to many. But do you realize the extent to which your lifestyle choices are putting your life at risk? Can you identify a heart attack when it occurs? Take our quiz and find out.

"Those who had ezetimibe added did not appear to have a better outcome. So for the moment, the data supports the use of high-potency statins and one of which, atorvastatin, is now off patent and is cheap and effective," said Lang.

Researchers looked at the data for patients who had survived 30 days after their first heart attack, who had not received prior statin or ezetimibe therapy, and who were started on a statin within that period of their attack.

Blood Transfusions May Be Fatal in Heart Attack Patients
Research has revealed that blood transfusion received while treating a heart attack is capable of causing more harm than good.

The results were published in the journal Heart.

Source-IANS